Add to Favorites Newsroom RSS Share
Philadelphia, PA USA

Our News on Newswise

Penn Medicine | Virtua Strategic Alliance Brings First Proton Therapy to South Jersey

Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua’s acute care hospital, Virtua Voorhees. The new $35 million center, which...
14-Dec-2017 4:40 PM EST Add to Favorites

Penn Researcher Receives $4M State Award for Multi-Institution Effort to Transform Prevention, Diagnosis, and Treatment of Traumatic Brain Injury

Douglas H. Smith, MD, the Robert A. Groff Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania, has received a $4-million, four-year PACT (PA Consortium on Traumatic Brain Injury) award from the Pennsylvania...
14-Dec-2017 2:35 PM EST Add to Favorites

“Human Chronobiome” Study Informs Timing of Drug Delivery, Precision Medicine Approaches

SkarkeFitzGeraldSciReportsimageDec2017.jpg

A pilot study collected physiological information from six healthy young male volunteers as they went about their normal daily lives. Thousands of indicators were measured with wearable devices and smart phone apps. The study showed the feasibility...
13-Dec-2017 1:05 PM EST Add to Favorites

Racial Minorities Less Likely to See a Doctor for Psoriasis

SeverePsoriasis.jpg

Despite the fact that their disease may be more severe, a new study shows minorities are less likely than white Americans to see a doctor for psoriasis treatment. Researchers from the Perelman School of Medicine at the University of Pennsylvania...
13-Dec-2017 8:05 AM EST Add to Favorites

Kyra’s Legacy

RothMasonGoldendog.jpg

Pets have become an integral part of human medical research. However, a recent collaboration between Penn Med and Penn Vet has turned the tables on the arrangement.
11-Dec-2017 4:05 PM EST Add to Favorites

CAR T, Immunotherapy Bring New Hope for Multiple Myeloma Patients

Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the treatment of multiple myeloma patients who had relapsed and were resistant to other therapies. Researchers...
8-Dec-2017 9:05 AM EST Add to Favorites

Global CAR T Therapy Trial Shows High Rates of Durable Remission for Non-Hodgkin’s Lymphoma

In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah™ (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin’s lymphoma (NHL) patients. Results...
7-Dec-2017 2:05 PM EST Add to Favorites

New Mediola and OlympiAD Trial Results Offer Another Boon for PARP Inhibitors in Treatment of Advanced BRCA-Related Breast Cancer

Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to two studies presented this week at the annual San Antonio Breast Cancer Symposium. Susan Domchek, MD, executive director of the...
5-Dec-2017 9:05 PM EST Add to Favorites

Our YouTube Videos





Chat now!